Loading institutional data...
Loading institutional data...
Held by 342 of 2,417 reporting institutions (97th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (136%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $649.9M dividends + $3.4M buybacks = $653.3M returned on $477.8M FCF.
3 consecutive years of dividend increases · 7%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-29
Where each multiple sits in its own 14-yr range · 51th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 8% against ROIC 8% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 8.7% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Income Tax | -8.1 | 12.5 | 14.4 | 8.6 | 2.2 | 8.3 | 4.4 | 4.9 |
| Net Income | 47.2 | 47.5 | 47.3 | 29.2 | -9.1 | 25.7 | 14.1 | 12.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on KKR: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.46B 100.0% | $21.88B 100.0% | $14.50B 100.0% | $5.70B 100.0% | $16.23B 100.0% | $4.23B 100.0% | $4.22B 100.0% | $2.40B 100.0% | $3.56B 100.0% | $2.04B 100.0% |
| Interest Expense | $2.78B 14.3% | $3.03B 13.9% | $2.77B 19.1% | $1.55B 27.2% | $1.07B 6.6% | $969.9M 22.9% | $1.04B 24.7% | $876.0M 36.6% | $808.9M 22.7% | $790.0M 38.7% |
| Interest & Investment Income | $3.18B 16.3% | $3.46B 15.8% | $3.37B 23.2% | $1.90B 33.2% | $1.49B 9.2% | $1.40B 33.2% | $1.42B 33.6% | $1.40B 58.3% | $1.24B 34.9% | $1.02B 50.1% |
| Pretax Income | $7.10B 36.5% | $5.86B 26.8% | $6.55B 45.2% | -$292.2M -5.1% | $13.85B 85.3% | $5.73B 135.4% | $5.17B 122.4% | $2.26B 94.2% | $2.78B 78.3% | $975.2M 47.8% |
| Income Tax Expense | $953.7M 4.9% | $954.4M 4.4% | $1.20B 8.3% | $125.4M 2.2% | $1.39B 8.6% | $609.1M 14.4% | $528.8M 12.5% | -$194.1M -8.1% | $224.3M 6.3% | $24.6M 1.2% |
| Net Income | $2.37B 12.2% | $3.08B 14.1% | $3.73B 25.7% | -$521.7M -9.1% | $4.73B 29.2% | $2.00B 47.3% | $2.01B 47.5% | $1.13B 47.2% | $1.02B 28.6% | $309.3M 15.2% |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
$4.39B of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2021-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $95.82 today, the market must believe free cash flow compounds 15.1%/yr for a decade (off $3.56B on the 3-yr avg basis).
On the basis ($2.83B) the requirement is 18.5%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 15.1% is more optimistic than its 1-yr track record.
Default is 12.6% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.90B shares (market data) · net debt $0
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 25 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BX | $90.5B | 31.2× | — | 6.3× | 9.2% | — | 20.9% | 34.8% | 14.2% | — | 721 |
| KKR | $86.0B | — | — | 4.4× | -11.0% | — | 12.2% | 7.7% | 7.7% | — | 342 |
| APO | $70.0B | 21.4× | — | 2.2× | 22.7% | — | 10.9% | 15.0% | 9.5% | — | — |
| AMP | $44.0B | 13.7× | — | 2.3× | 5.5% | — | 18.8% | 54.4% | 54.4% | — | 444 |
| TROW | $22.7B | 11.5× | — | 3.1× | 3.1% | — | 28.5% | 19.2% | 19.2% | — | 372 |
| BEN | $16.4B | 35.5× | 25.8× | 1.9× | 3.5% | — | 6.0% | 4.3% | 3.6% | 3.2× | 189 |
| CG | $14.5B | 18.6× | 9.2× | 3.0× | -11.9% | — | 16.9% | 11.5% | 11.5% | -1.5× | 146 |
| EVR | $11.4B | 21.2× | — | 3.0× | 29.5% | — | 15.3% | 29.1% | 29.1% | — | 147 |
| AMG | $10.3B | 17.6× | — | 5.0× | 1.6% | — | 34.5% | 22.1% | 12.1% | — | 131 |
| HLI | $9.7B | 22.4× | 15.0× | 3.7× | 9.5% | — | 16.3% | 18.2% | 18.2% | -2.1× | 125 |
| MORN | $8.3B | 25.1× | 12.5× | 3.4× | 7.5% | 61.0% | 15.3% | 30.6% | 16.3% | 0.8× | 92 |
| TPG | $8.0B | 106.5× | 12.3× | 1.7× | 33.4% | — | 4.0% | 4.5% | 3.2% | 1.2× | 67 |
| OWL | $7.1B | 104.1× | 21.4× | 12.5× | 7.6% | — | 13.9% | 3.6% | 1.4% | 6.5× | 138 |
| VCTR | $7.0B | 27.9× | 14.2× | 5.4× | 46.2% | — | 25.3% | 13.6% | 9.7% | 1.5× | 88 |
| FHI | $4.3B | 11.3× | 7.8× | 2.4× | 10.3% | — | 22.4% | 33.7% | 26.1% | -0.5× | 96 |
| LAZ | $3.9B | 18.2× | 11.3× | 1.2× | 1.5% | — | 7.4% | 27.2% | 9.3% | 0.6× | 77 |
| CNS | $3.7B | 24.6× | 19.2× | 6.7× | 7.5% | — | 27.6% | 27.3% | 27.3% | -0.8× | 65 |
| APAM | $2.6B | 9.0× | 6.8× | 2.2× | 7.6% | — | 24.3% | 66.2% | 46.2% | 0.5× | 79 |
| RPC | $1.0B | 54.6× | 20.3× | 3.4× | 0.3% | — | 6.6% | 4.8% | 2.5% | 5.1× | — |
| ABX | $842M | 23.9× | 11.3× | 3.6× | 110% | 87.7% | 15.5% | 8.7% | 4.4% | 3.4× | 19 |
| VRTS | $828M | 6.3× | 5.2× | 1.0× | -6.0% | — | 15.9% | 14.6% | 10.3% | 1.7× | 40 |
| GCMG | $771M | 30.0× | 6.9× | 1.4× | 8.5% | — | 8.1% | 168% | 10.0% | 1.4× | 18 |
| NOAH | $473M | 30.0× | — | 1.3× | 4.8% | — | 21.4% | 5.7% | 5.7% | — | 9 |
| HKHC | $381M | 75.8× | 28.2× | 5.2× | 30.5% | — | 7.0% | 1.5% | 1.5% | -3.0× | — |
| WHG | $181M | 24.0× | 28.2× | 1.9× | 3.2% | — | 7.2% | 5.6% | 5.6% | -4.8× | 14 |
Peers = companies sharing KKR's sector (Investment Advice) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | not reported | 15.2% |
| FY2017 | not reported | not reported | 28.6% |
| FY2018 | not reported | not reported | 47.2% |
| FY2019 | not reported | not reported | 47.5% |
| FY2020 | not reported | not reported | 47.3% |
| FY2021 | not reported | not reported | 29.2% |
| FY2022 | not reported | not reported | -9.1% |
| FY2023 | not reported | not reported | 25.7% |
| FY2024 | not reported | not reported | 14.1% |
| FY2025 | not reported | not reported | 12.2% |
Return on equity (8%) and return on invested capital (8%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Cash conversion of -0.51x sits below the level that would make the earnings clearly cash-backed.
Reported free cash flow is $478M; after share-based compensation it is -$244M. The difference is a real cost that the cash flow statement adds back.
No debt, so there is no leverage path to distress.
This schedule comes from a filing dated 2021-12-31, 1764 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2021-12-31 (10-K); cash from the 2021-12-31 balance sheet; FCF from FY2021. No cash figure on the matching balance sheet, so no coverage line is drawn.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
At $95.82, free cash flow must compound 15.14%/yr for 10 years. It has no positive compounding record to compare against, though across a reporting-basis change.
The achieved growth rate spans a reporting-basis change in FY2022, so part of it measures the restatement rather than the business.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Step | Amount | Running total |
|---|---|---|
| Net income | $2.37B | $2.37B |
| Share-based comp | $722M | $3.09B |
| Other non-cash & working capital | −$2.61B | $478M |
| Operating cash flow | $478M | $478M |
| Capex | $0 | $478M |
| Free cash flow | $478M | $478M |
| FCF after SBC | −$244M | −$244M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 0.2% | not reported | not reported |
| FY2021 | 283.5% | not reported | not reported |
| FY2022 | -64.8% | not reported | not reported |
| FY2023 | 154.2% | not reported | not reported |
| FY2024 | 50.9% | not reported | not reported |
| FY2025 | -11.0% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | 12.6 percent |
| FY2020 | 10.0 percent |
| FY2021 | not reported |
| FY2022 | 1.7 percent |
| FY2023 | 1.6 percent |
| FY2024 | -1.0 percent |
| FY2025 | 0.5 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Lee Brian J Director | Grant | 163 | $0.00 | $0 |
| 2026-09-08 | 2 co-filers Co-Chief Executive Officer | Gift | 122,403 | $0.00 | $0 |
| 2026-09-08 | 2 co-filers Co-Chief Executive Officer | Giftindirect | 345,849 | $0.00 | $0 |
| 2026-09-03 | 3 co-filers Chief Administrative Officer | Open-market sale | 10,000 | $108.58 | $1.1m |
| 2026-09-02 | Lewin Robert H Chief Financial Officer | Gift | 10,000 | $0.00 | $0 |
| 2026-09-02 | 3 co-filers Chief Administrative Officer | Option exercise | 10,000 | — | — |
| 2026-09-02 | 3 co-filers Chief Administrative Officer | Option exercise | 10,000 | $0.00 | — |
| 2026-04-29 | Sudol Kathryn King Chief Legal Officer & GC | Grant | 300,000 | $0.00 | — |
| 2026-04-29 | Lewin Robert H Chief Financial Officer | Grant | 650,000 | $0.00 | — |
| 2026-03-04 | Barakett Timothy R Director | Open-market buyindirect | 50,000 | $94.47 | $4.7m |
| 2026-03-02 | Dillon Mary N Director | Open-market buyindirect | 22,225 | $90.96 | $2.0m |
| 2026-02-27 | Nuttall Scott C Co-Chief Executive Officer | Open-market buy | 50,000 | $87.81 | $4.4m |
| 2026-02-27 | Bae Joseph Y Co-Chief Executive Officer | Open-market buyindirect | 50,000 | $88.56 | $4.4m |
| 2026-02-17 | Cohler Matt Director | Open-market buy | 43,872 | $102.90 | $4.5m |
| 2026-02-17 | 4 co-filers Co-Chief Executive Officer | Open-market buyindirect | 22,801 | $100.39 | $2.3m |
| 2026-02-17 | 3 co-filers Co-Chief Executive Officer | Open-market buy | 34,761 | $102.13 | $3.6m |
| 2026-02-17 | 3 co-filers Co-Chief Executive Officer | Open-market buy | 90,127 | $102.87 | $9.3m |
| 2026-02-17 | 4 co-filers Co-Chief Executive Officer | Open-market buyindirect | 8,650 | $101.30 | $876k |
| 2026-02-17 | 4 co-filers Co-Chief Executive Officer | Open-market buyindirect | 63,467 | $102.49 | $6.5m |
| 2026-02-17 | 3 co-filers Co-Chief Executive Officer | Open-market buy | 112 | $103.41 | $12k |
| 2026-02-17 | 4 co-filers Co-Chief Executive Officer | Open-market buyindirect | 30,082 | $103.17 | $3.1m |
| 2026-02-09 | Barakett Timothy R Director | Open-market buyindirect | 50,000 | $104.93 | $5.2m |
| 2025-12-11 | Spiegel Evan Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Scully Robert W Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Russo Patricia F Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Ross Kimberly A. Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Niel Xavier Bruno Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Gutierrez Arturo Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Dillon Mary N Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Cohler Matt Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Brown Adriane M Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Barakett Timothy R Director | Grant | 1,605 | $0.00 | $0 |
| 2025-12-11 | Arnold Craig Director | Grant | 1,605 | $0.00 | $0 |
| 2025-11-12 | Kravis Henry R Co-Executive Chairman | Giftindirect | 350,000 | $0.00 | $0 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.